Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia

Figure 5

Hsp90 inhibitors of microbial origin.

(a) Geldanamycin

(b) 17-AAG

(c) 17-DMAG

(d) Ganetespib

(e) Herbimycin A

(f) Macbecin

(g) Radicicol

(h) KF25706

(i) Novobiocin